JP2012039997A - Method for producing seed-containing pomegranate fruit juice, seed-containing pomegranate fruit juice obtained by using the method and pomegranate fruit juice-containing jelly obtained by using seed-containing pomegranate fruit juice - Google Patents
Method for producing seed-containing pomegranate fruit juice, seed-containing pomegranate fruit juice obtained by using the method and pomegranate fruit juice-containing jelly obtained by using seed-containing pomegranate fruit juice Download PDFInfo
- Publication number
- JP2012039997A JP2012039997A JP2010277818A JP2010277818A JP2012039997A JP 2012039997 A JP2012039997 A JP 2012039997A JP 2010277818 A JP2010277818 A JP 2010277818A JP 2010277818 A JP2010277818 A JP 2010277818A JP 2012039997 A JP2012039997 A JP 2012039997A
- Authority
- JP
- Japan
- Prior art keywords
- pomegranate
- juice
- seed
- filtration
- seeds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000014360 Punica granatum Nutrition 0.000 title claims abstract description 124
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 40
- 235000015110 jellies Nutrition 0.000 title claims abstract description 33
- 239000008274 jelly Substances 0.000 title claims abstract description 33
- 235000015203 fruit juice Nutrition 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 15
- 241000219991 Lythraceae Species 0.000 title claims abstract 23
- 238000001914 filtration Methods 0.000 claims abstract description 55
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 30
- 230000001954 sterilising effect Effects 0.000 claims abstract description 15
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims description 97
- 235000013525 pomegranate juice Nutrition 0.000 claims description 97
- 102000008186 Collagen Human genes 0.000 claims description 34
- 108010035532 Collagen Proteins 0.000 claims description 34
- 229920001436 collagen Polymers 0.000 claims description 34
- 229940011871 estrogen Drugs 0.000 claims description 19
- 239000000262 estrogen Substances 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 18
- 239000011148 porous material Substances 0.000 claims description 17
- 239000000701 coagulant Substances 0.000 claims description 13
- 239000000835 fiber Substances 0.000 claims description 12
- 210000002826 placenta Anatomy 0.000 claims description 12
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims description 11
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 claims description 10
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 claims description 10
- 229960003399 estrone Drugs 0.000 claims description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 9
- 239000011707 mineral Substances 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 239000001814 pectin Substances 0.000 claims description 8
- 235000010987 pectin Nutrition 0.000 claims description 8
- 229920001277 pectin Polymers 0.000 claims description 8
- 229960005309 estradiol Drugs 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 230000003020 moisturizing effect Effects 0.000 claims description 7
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 229920002674 hyaluronan Polymers 0.000 claims description 6
- 229960003160 hyaluronic acid Drugs 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000005715 Fructose Substances 0.000 claims description 5
- 229930091371 Fructose Natural products 0.000 claims description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 229910000831 Steel Inorganic materials 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 5
- 235000013325 dietary fiber Nutrition 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 5
- 235000013824 polyphenols Nutrition 0.000 claims description 5
- 239000010959 steel Substances 0.000 claims description 5
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 claims description 4
- 229960001348 estriol Drugs 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract description 6
- 244000294611 Punica granatum Species 0.000 description 101
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000011259 mixed solution Substances 0.000 description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 8
- 229930003268 Vitamin C Natural products 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 8
- 235000019154 vitamin C Nutrition 0.000 description 8
- 239000011718 vitamin C Substances 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 235000003599 food sweetener Nutrition 0.000 description 5
- 235000019719 rose oil Nutrition 0.000 description 5
- 239000010666 rose oil Substances 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000013329 compounding Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000003075 phytoestrogen Substances 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 229930182833 estradiol Natural products 0.000 description 3
- 230000001076 estrogenic effect Effects 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000009245 menopause Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 244000045195 Cicer arietinum Species 0.000 description 1
- 235000010523 Cicer arietinum Nutrition 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010049290 Feminisation acquired Diseases 0.000 description 1
- 208000034793 Feminization Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 240000004533 Hesperis matronalis Species 0.000 description 1
- 235000015847 Hesperis matronalis Nutrition 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 244000043158 Lens esculenta Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000010659 Phoenix dactylifera Nutrition 0.000 description 1
- 244000104275 Phoenix dactylifera Species 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 241000200487 Rhigozum obovatum Species 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000010485 coping Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 235000021332 kidney beans Nutrition 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940094984 other estrogen in atc Drugs 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 238000011085 pressure filtration Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Landscapes
- Jellies, Jams, And Syrups (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
本発明は、ザクロの果肉及び種子を同時にすりつぶした種子入りザクロジュースの製造方法、その製造方法を使用して成る種子入りザクロジュース及び前記種子入りザクロジュースを使用して成るザクロ果汁入りゼリーに関する。 The present invention relates to a method for producing a pomegranate juice containing seeds obtained by simultaneously grinding the pomegranate pulp and seeds, a pomegranate juice containing seeds using the production method, and a jelly containing pomegranate juice using the pomegranate juice containing seeds.
生理不順、生理痛、冷え性、肩こり、めまい、体の火照り、発汗異常など女性の更年期障害の症状は、近年若い世代(20代〜30代)にも現れる傾向があるが、これらは主に自律神経の失調やストレスなどの心因性のもの、若しくは食生活の変化などが原因として挙げられるが、根本の原因は女性ホルモンの分泌異常(分泌過多若しくは減少)である。 Symptoms of climacteric disorders in women such as irregular menstrual periods, menstrual pain, coldness, stiff shoulders, dizziness, hot flashes, and sweating abnormalities tend to appear in younger generations (20s-30s) in recent years, but these are mainly autonomous. Possible causes include psychological disorders such as nerve malfunction and stress, and changes in dietary habits, but the underlying cause is abnormal secretion of female hormones (oversecretion or decrease).
女性ホルモンの中でも卵胞由来のエストロゲンは、全身の女性化を促進し、子宮や膣などの発達や機能を維持する働きがある。エストロゲンは、単に更年期障害による減少だけでなく、無理なダイエットなどでも減少し、ホルモンバランスが崩れる。ここで、この対処療法としてエストロゲン経口剤服用がある。しかし、エストロゲン経口剤の服用は、作用が強すぎ、乳房痛、乳がん、子宮ガン及び肝機能障害の発生又はそれらの促進といった副作用を伴う場合があると報告されている。 Among female hormones, estrogen derived from follicles promotes feminization of the whole body and has a function of maintaining the development and function of the uterus and vagina. Estrogens are not only reduced due to menopause, but are also reduced by an unreasonable diet and the hormone balance is lost. Here, there is oral estrogen as a coping therapy. However, it has been reported that taking estrogen orally is too strong and may have side effects such as breast pain, breast cancer, uterine cancer and liver dysfunction or their promotion.
こうして、更年期障害を改善するため若しくは女性生殖機能維持のためのエストロゲンの補充と、逆にエストロゲン過剰摂取による乳がん等の促進という相反する効果に対応することが長年の研究課題である。 Thus, it has been a long-standing research subject to cope with the conflicting effects of estrogen supplementation to improve menopause or to maintain female reproductive function, and conversely, promotion of breast cancer and the like by excessive intake of estrogen.
一方、植物性食品(天然物)に由来するエストロゲン様活性物質はフィトエストロゲンと呼ばれ、これを含む食品は、更年期障害に伴う骨粗鬆症及び高脂血症の予防、肥満などの予防、乳がん、子宮がんの予防又は治療に有効であると考えられている。そして、該食品は、エストロゲン経口剤のように即効性は無いものの、摂取した場合に過剰摂取とはならず、それ故該経口剤摂取による副作用も殆どない。このようなフィトエストロゲン(植物性エストロゲン)には、大豆、ヒヨコマメ、ヒラマメ等の豆類に含まれるイソフラボン、穀物、果実、野菜に含まれるリグナン、リンゴ、カンゾウ、インゲンマメ、ナツメヤシ、ザクロに含まれる植物性(天然物)由来エストロゲンなどが含まれている。これらの中では、例えばザクロが注目されている。 On the other hand, estrogenic active substances derived from plant foods (natural products) are called phytoestrogens, and foods containing them are used to prevent osteoporosis and hyperlipidemia associated with menopause, prevention of obesity, breast cancer, uterus, etc. It is considered effective in preventing or treating cancer. And although this food does not have an immediate effect like an estrogen oral preparation, when it is ingested, it does not become an excessive intake, and therefore there is almost no side effect by ingesting the oral preparation. Such phytoestrogens (phytoestrogens) include isoflavones contained in beans such as soybeans, chickpeas and lentils, lignans contained in cereals, fruits and vegetables, phytoestrogens contained in apples, licorice, kidney beans, date palms and pomegranates. Contains (natural products) derived estrogens. Among these, for example, pomegranates are attracting attention.
ザクロは、学名をプニカ・グラナタム(Punica・granatum)といい、トルコ若しくはイランなどの西南アジア、南ヨーロッパ、北アフリカが原産地とされている。ザクロの可食部については後述するが、ザクロの樹皮や根皮は、駆虫薬として、ザクロの果皮や花は、主に消毒薬としてそれぞれ用いられるなど、古くから薬としての効能が知られている。また、ザクロの種子に関しては、1964年に、Sharafらが種子油にエストロゲン活性があることを見出し、更にカルフォルニア工科大学のHefutmannらによってこの活性がエストロンになることが示され、また更に乾燥ザクロ種子(主に繊維質部分)100g中に1mgのエストロンが含まれることMoneamらによって確認された。 The pomegranate is called Punica granatum, and its origin is in Southwest Asia such as Turkey or Iran, Southern Europe, and North Africa. Although the edible part of pomegranate will be described later, pomegranate bark and root bark are used as antiparasitic drugs, and pomegranate peel and flowers are mainly used as disinfectants. Yes. As for pomegranate seeds, in 1964, Sharaf et al. Found that seed oil had estrogenic activity, and Heftmann et al. Of California Institute of Technology showed that this activity was estrone, and further dried pomegranate seeds. It was confirmed by Moneam et al. That 1 mg of estrone was contained in 100 g (mainly the fibrous part).
このように、種子に含まれている成分若しくは乾燥ザクロ種子を配合した薬剤などが近年開発されており、例えば特開2002−105483号公報(特許文献1)に開示されている方法がある。この方法は、種衣部及び糖質の付着量の少ない、種子油製造に適した乾燥ザクロ種子を得ることが目的である。しかしながら、特許文献1に記載の方法は、種衣部及び糖質の除去を行う目的で硫酸や塩酸などの強酸、水酸化カリウム水溶液などの強アルカリを用いるため、エストロンやエストラジオールを含むザクロ種子の繊維質部分を溶解してしまう可能性があること、さらにエストロンやエストラジオールが、酸又はアルカリ処理液に混入してしまう可能性がある。 As described above, a component containing seeds or a drug containing dry pomegranate seeds has been developed in recent years. For example, there is a method disclosed in Japanese Patent Application Laid-Open No. 2002-105483 (Patent Document 1). The purpose of this method is to obtain dried pomegranate seeds suitable for seed oil production with a small amount of seed coat and sugar. However, the method described in Patent Document 1 uses a strong acid such as sulfuric acid or hydrochloric acid or a strong alkali such as an aqueous potassium hydroxide solution for the purpose of removing seed coat parts and sugars, so that pomegranate seeds containing estrone and estradiol are used. There is a possibility that the fibrous portion will be dissolved, and further, estrone or estradiol may be mixed into the acid or alkali treatment liquid.
一方、古くからザクロの可食部は、果実から皮と種子を取り除いた果肉とされている。果肉は、生食や果肉を絞ったジュース(果汁)が飲料として摂取される。この果汁若しくは果肉にもまた、ザクロ種子同様にエストロゲンが含まれるとして、2000年代初頭にブームとなったが、一般に流通している果肉(果汁)から成るザクロジュースやエキス錠剤などを用いた国民生活センターの分析では、いずれもエストロゲンは検出されなかった。 On the other hand, the edible part of pomegranate has long been regarded as the pulp from which the skin and seeds have been removed from the fruit. As for the pulp, raw food and juice (fruit juice) obtained by squeezing the pulp are ingested as beverages. This fruit juice or flesh also contains estrogen as well as pomegranate seeds, and it became a boom in the early 2000s. However, the national life using pomegranate juice and extract tablets made from commonly distributed fruit (juice) Neither estrogen was detected in any of the center's analyses.
こうした背景もあり、エストロゲンを、経口剤などの薬剤で摂取するという方法ではなく、ジュース等の飲食品として摂取できるようなザクロ種子入り飲食品の開発が、例えば特開2003−274888号公報(特許文献2)や特許第3785424号公報(特許文献3)に開示されている。特許文献2に記載の発明は、ザクロなどの果物を全果、即ち果皮、種子、果肉などを丸ごと磨砕し、得られた磨砕物に添加物を加えて飲食品にするという発明である。また、特許文献3に記載の発明は、ザクロ種子の成分を水で抽出し、該抽出物をザクロ果汁と乳酸発酵用原液と混合して乳酸菌発酵飲料を得るという発明である。
Against such a background, development of food and drink containing pomegranate seeds that can be taken as food and drink such as juice, rather than a method of taking estrogen as a drug such as an oral preparation, is disclosed in, for example, Japanese Patent Application Laid-Open No. 2003-274888 (patent) Document 2) and Japanese Patent No. 3785424 (Patent Document 3). The invention described in
しかしながら、特許文献2に記載の磨砕物は、飲食品として用いるとき、該磨砕物の粒径に風味や栄養分の含有量が依存すること、更にビタミンC、ビタミンB類、果糖やブドウ糖などの糖類、ミネラル分など元来ザクロ果実に含まれているこれらの成分を食品添加物として添加することにより補わなくてはならないことが問題点である。また、特許文献3に記載の飲料は、ザクロ種子の成分を飲料に含有させるに際し、種子を一旦水で抽出したものを使用しなくてはならないことが問題点である。
However, when the ground product described in
以上のように、女性にとっての健康維持及び美容におけるザクロの性質(効能)が見直されているが、一方で、美容の部分、特に美肌成分を司るコラーゲン成分については、ザクロには含有されていない。この様な場合、ザクロとコラーゲン成分を一度に摂取することが望ましいが、ザクロ果汁のpH(水素イオン濃度)値が強い(pH<2)ため、コラーゲン成分と併せた場合、コラーゲン成分が分解してしまうといった問題点があった。なお、ベリー類などの酸性果汁とコラーゲン成分との反応を制御する技術が特許第3574612号公報(特許文献4)に開示されているが、特許文献4に記載の技術は、ザクロ果汁に対しては用いられていない。 As described above, the nature (efficacy) of pomegranate in health maintenance and beauty for women has been reviewed, but on the other hand, the cosmetic component, particularly the collagen component that controls the skin beautifying component, is not contained in pomegranate. . In such a case, it is desirable to ingest pomegranate and collagen components at once, but the pH (hydrogen ion concentration) value of pomegranate juice is strong (pH <2), so when combined with the collagen component, the collagen component decomposes. There was a problem such as. In addition, although the technique which controls reaction of acidic fruit juices, such as berries, and a collagen component is disclosed by patent 3574612 (patent document 4), the technique of patent document 4 is based on pomegranate juice. Is not used.
以上の事情に鑑み、本発明の目的は、種子入りザクロジュースの製造方法、その製造方法を使用して成る種子入りザクロジュース、更に前記種子入りザクロジュースを使用して成るザクロ果汁入りゼリーを提供することにある。 In view of the above circumstances, an object of the present invention is to provide a method for producing pomegranate juice containing seeds, a pomegranate juice containing seeds using the production method, and a jelly containing pomegranate juice formed using the pomegranate juice containing seeds. There is to do.
本発明に係る製造方法の上記目的は、ザクロを集荷し、ベルトコンベア上で選別する工程と、前記ザクロ全果を潰し、前記ザクロ全果から果皮を取り除き、果肉及び種子から成る果実部分を残す工程と、前記果実部分について、前記種子及び前記果肉とに分離し、前記果肉を搾って果汁にする工程と、前記種子を粒状になるまで潰す工程と、粒状の前記種子と前記果汁から成るザクロ混合液を滅菌する工程と、該滅菌工程後、前記ザクロ混合液を2回に分けて濾過をする濾過工程と、前記濾過後、前記ザクロ混合液を加熱濃縮する工程とを具備する種子入りザクロジュースの製造方法であって、前記濾過工程は、粗い孔を有するフィルタで濾過をする第1濾過と、前記第1濾過で使用されるフィルタよりも孔径の小さいフィルタで濾過をする第2濾過とを具備することで効果的に達成される。 The purpose of the production method according to the present invention is to collect the pomegranate and sort it on a belt conveyor, to crush the whole pomegranate fruit, to remove the skin from the whole pomegranate fruit, and to leave a fruit portion consisting of flesh and seed A step of separating the fruit part into the seed and the pulp, squeezing the pulp into fruit juice, crushing the seed until it becomes granulated, and the pomegranate comprising the granular seed and the fruit juice A seed-filled pomegranate comprising a step of sterilizing the mixed solution, a filtration step of filtering the pomegranate mixed solution in two after the sterilization step, and a step of heating and concentrating the pomegranate mixed solution after the filtration In the method for producing a juice, the filtering step includes filtering with a filter having a coarse pore and a filter having a pore diameter smaller than that of the filter used in the first filtration. Effectively achieved by and a 2 filtration.
更に、前記ザクロがイラン・ザクロス山脈産の赤身ザクロ及び/又は黒ザクロであることにより、或いは前記ザクロが9〜11月に収穫されることにより、或いは前記滅菌は、60〜95℃で30〜50分間行うことにより、或いは前記第1濾過で使用されるフィルタの孔径が1.0〜1.5mmであることにより、或いは前記第2濾過で使用されるフィルタの孔径が0.1〜0.3mmであることにより、或いは前記第1濾過及び/又は前記第2濾過で使用されるフィルタの材質がスチール製であることにより、或いは前記加熱濃縮は、前記混合液をBrix65±1%に濃縮することにより、より効果的に達成される。 Furthermore, the pomegranate is a red pomegranate and / or a black pomegranate from the Iranian Zakros Mountains, or the pomegranate is harvested in September-November, or the sterilization is performed at 60-95 ° C. for 30-30 By performing for 50 minutes, or when the pore size of the filter used in the first filtration is 1.0 to 1.5 mm, or the pore size of the filter used in the second filtration is 0.1 to 0. By being 3 mm, or when the material of the filter used in the first filtration and / or the second filtration is made of steel, or by the heat concentration, the mixed solution is concentrated to Brix 65 ± 1%. This is achieved more effectively.
また、本発明は、上記製造方法を使用して成る種子入りザクロジュースであって、前記種子入りザクロジュースは、種子由来繊維質成分、蛋白質、ブドウ糖、果糖、ミネラル類、ナトリウム、ポリフェノールを含み、更に前記種子由来繊維質成分に、エストロゲン類が付着して成ることにより効果的に達成される。 Further, the present invention is a pomegranate juice containing seeds using the above production method, wherein the pomegranate juice containing seeds contains a seed-derived fiber component, protein, glucose, fructose, minerals, sodium, polyphenol, Furthermore, it is effectively achieved by adhering estrogens to the seed-derived fiber component.
更に、前記ミネラル類が、カリウム及びカルシウムであることにより、或いは前記種子由来繊維質成分が食物繊維であることにより、或いは前記エストロゲン類がエストロン、17β−エストラジオール及びエストリオールであることにより、より効果的に達成される。 Further, the minerals are potassium and calcium, or the seed-derived fiber component is dietary fiber, or the estrogens are estrone, 17β-estradiol and estriol. Is achieved.
また、本発明は、上記種子入りザクロジュースを使用して成るザクロ果汁入りゼリーであって、前記ザクロ果汁入りゼリーは、コラーゲン類及び/又はプラセンタエキス、保湿成分並びに凝固剤を含み、前記コラーゲン類が、平均分子量1000〜3000の低分子化コラーゲンペプチドであり、前記コラーゲン類の配合量が、前記ザクロ果汁入りゼリー100重量%に対して、0.6〜5重量%であることによって効果的に達成される。 Further, the present invention is a jelly with pomegranate juice using the pomegranate juice with seeds, wherein the jelly with pomegranate juice contains collagens and / or placenta extract, a moisturizing component and a coagulant, and the collagens Is a low molecular weight collagen peptide having an average molecular weight of 1000 to 3000, and the amount of the collagen is effectively 0.6 to 5% by weight with respect to 100% by weight of the jelly with pomegranate juice. Achieved.
更に、前記プラセンタエキスが豚由来であることにより、或いは前記保湿成分がヒアルロン酸及び/又はトレハロースであることにより、或いは前記凝固剤がペクチンであることにより、より効果的に達成される。 Furthermore, it is more effectively achieved by the fact that the placenta extract is derived from pigs, the moisturizing component is hyaluronic acid and / or trehalose, or the coagulant is pectin.
本発明の製造方法により、エストロゲン(エストロゲン様活性物質も含む)、繊維質、ミネラル、糖質などが損なわれることなく、ザクロジュースを製造することが可能である。 According to the production method of the present invention, pomegranate juice can be produced without damaging estrogen (including estrogen-like active substances), fibers, minerals, saccharides and the like.
また、本発明のザクロ果汁入りゼリーにより、ザクロ由来成分はもとより、コラーゲン成分を同時に摂取することが可能となった。 Moreover, the jelly with pomegranate juice of the present invention makes it possible to ingest collagen components as well as pomegranate-derived components.
以下、本発明に係る種子入りザクロジュースの製造方法について、図面を用いて説明する。 Hereinafter, the method for producing seed-containing pomegranate juice according to the present invention will be described with reference to the drawings.
図1は、種子入りザクロジュースの製造方法を示すフローチャートである。 FIG. 1 is a flowchart showing a method for producing seeded pomegranate juice.
ステップS1では、ザクロを収穫し、集荷する。本発明に係る種子入りザクロジュースの製造方法で使用するザクロは、赤身ザクロ、水晶ザクロ、黄ザクロ、黒ザクロ、白ザクロなど種類は問わず、また、産地もイラン、中国、日本産等特に問わないが、本発明ではイラン・ザクロス山脈産の赤身ザクロ及び/又は黒ザクロを使用することが好ましい。更に、赤身ザクロのみ、黒ザクロのみでも本発明に係る種子入りザクロジュースの製造は可能であるが、赤身ザクロと、黒ザクロとを混合させることが好ましい。また更に、白ザクロを混合しても良い。なお、本発明においては、白ザクロ、赤身ザクロ及び黒ザクロの混合比率は、適宜選択可能である。 In step S1, the pomegranate is harvested and collected. The pomegranate used in the method for producing seeded pomegranate juice according to the present invention is not limited to red pomegranate, crystal pomegranate, yellow pomegranate, black pomegranate, white pomegranate, etc. In the present invention, it is preferable to use a red pomegranate and / or a black pomegranate from the Iran-Zakros Mountains. Furthermore, the pomegranate juice containing seeds according to the present invention can be produced using only red pomegranate or black pomegranate, but it is preferable to mix red pomegranate and black pomegranate. Further, white pomegranate may be mixed. In the present invention, the mixing ratio of white pomegranate, red pomegranate and black pomegranate can be selected as appropriate.
また、イラン・ザクロス山脈産の赤身ザクロ及び/又は黒ザクロを使用することが好ましい理由として、イラン・ザクロス山脈付近は、昼夜の気温差が激しいため、害虫が殆ど存在せず、赤身ザクロ及び黒ザクロを無農薬で生育可能なこと、昼は紫外線が強くザクロの抗酸化力(具体的には、ポリフェノール類の増加)が自然に増すという理由からである。そのため、イラン産(特に前記ザクロス山脈付近)のザクロは、ザクロ1個あたりの果汁が65%前後のものが殆どである。ちなみにザクロ1個あたりの果汁の平均は、25%前後である。また、ザクロの収穫時期は9月〜11月に収穫することが望ましい。この時期に糖度(甘み)が最大になるからである。 In addition, it is preferable to use red pomegranate and / or black pomegranate from the Iranian Zakros Mountains because the temperature difference between the Iran and Zakros Mountains is so intense that there are almost no pests. This is because pomegranate can grow without pesticides, because the ultraviolet rays are strong in the daytime and the antioxidant power of pomegranate (specifically, the increase in polyphenols) naturally increases. Therefore, most pomegranates from Iran (especially in the vicinity of the Zakros Mountains) have around 65% fruit juice per pomegranate. By the way, the average fruit juice per pomegranate is around 25%. The pomegranate is preferably harvested from September to November. This is because the sugar content (sweetness) becomes maximum at this time.
ステップS1にてザクロを収穫後、ベルトコンベア上にて選別し、洗浄をする(ステップS2)。ステップS2における選別は、傷のついているザクロ、未成熟なザクロ及び汚れているザクロを取り除くためで、従来技術に従えば良い。洗浄もまた、従来技術に従えば良い。なお、本発明に係る種子入りザクロジュース1kgに対し、約9〜11kgのザクロが必要である。 After harvesting the pomegranate in step S1, it is sorted and washed on the belt conveyor (step S2). The selection in step S2 is to remove scratched pomegranates, immature pomegranates, and dirty pomegranates, and may be performed according to the prior art. Cleaning may also follow conventional techniques. In addition, about 9-11 kg of pomegranate is required for 1 kg of pomegranate juice containing seeds according to the present invention.
次に、選別したザクロ全果を潰す(粉砕する)(ステップS3)。ここで、ザクロ全果とは集荷して選別したザクロの実全体のことを指す。前記ザクロ全果を潰すための粉砕機は、ハンマーミル、ウィングミル、マスコロイダー(登録商標)など一般的な果実用粉砕機であれば粉砕機の種類などは特に制限は無い。また、粉砕機の代わりに手動で粉砕しても構わない。 Next, the selected whole pomegranate fruit is crushed (pulverized) (step S3). Here, the whole pomegranate fruit refers to the whole pomegranate fruit collected and selected. If the grinder for crushing the whole pomegranate fruit is a general fruit grinder such as a hammer mill, a wing mill, or a mascoloider (registered trademark), the kind of the grinder is not particularly limited. Moreover, you may grind manually instead of a grinder.
次に、粉砕したザクロ全果から果皮(外皮)のみを取り除き、果実部分を残す(ステップS4)。図2に示すように、ここで言う果実部分1とは、果肉2及び種子3からなり、果肉2が種子3を覆うようにして成る。なお、果皮は従来技術で取り除けば良い。
Next, only the pericarp (outer skin) is removed from the crushed whole pomegranate fruit to leave a fruit portion (step S4). As shown in FIG. 2, the fruit portion 1 referred to here includes a
次に、ステップS4にて残した果実部分に関し、更に果肉と種子とに一旦分離し、分離した果肉を潰して(搾って)果汁にする(ステップS5)。なお、ステップS5において、果肉と種子とに分離する際は、遠心分離機等で分離すれば良い。また、果汁にする作業に関しては従来技術で構わず、その際、果肉の外側を覆う皮については一緒に潰して構わない。 Next, regarding the fruit part left in step S4, it further isolate | separates once into a pulp and a seed, and crushes (squeezes) the isolate | separated pulp into fruit juice (step S5). In addition, what is necessary is just to isolate | separate with a centrifuge etc. when isolate | separating into a pulp and a seed in step S5. Moreover, regarding the operation to make fruit juice, the conventional technique may be used, and at that time, the skin covering the outside of the pulp may be crushed together.
次に、ステップS5にて分離した種子を押圧して、該種子を粒径が1.5mm程度の粒になるまで潰す(ステップS6)。ステップS6において、種子を潰すための押圧機は、スクリュー型押圧機、当て盤プレス機等が好ましいが、特に限定は無い。 Next, the seeds separated in step S5 are pressed, and the seeds are crushed until they become grains having a particle size of about 1.5 mm (step S6). In step S6, the pressing machine for crushing seeds is preferably a screw-type pressing machine, a cauldron pressing machine, or the like, but is not particularly limited.
なお、ステップS5にて果肉(果汁)と、種子とを一旦分離するとしたが、ステップS5の工程を省いてステップS4からステップS6へ移行することも可能である。 In addition, although pulp (fruit juice) and a seed were once isolate | separated in step S5, it is also possible to skip the process of step S5 and to transfer to step S6 from step S4.
次に、ステップS6にて潰した種子と、ステップS5にて分離した果汁とを混合し、該混合液を60〜95℃で30〜50分間殺菌する(ステップS7)。該滅菌は、従来技術で構わない。また、滅菌の温度範囲及び滅菌時間の範囲についてであるが、これらの範囲以下であると、十分滅菌されず、これらの範囲以上であると、前記混合液に含まれる成分が変質してしまうため、60〜95℃で30〜50分間殺菌することが好ましい。なお、ステップS7にて、果汁と種子の混合液を滅菌するとしたが、先に果汁のみを滅菌しても構わない。 Next, the seed crushed in step S6 and the fruit juice separated in step S5 are mixed, and the mixed solution is sterilized at 60 to 95 ° C. for 30 to 50 minutes (step S7). The sterilization may be performed by a conventional technique. Further, regarding the temperature range of sterilization and the range of sterilization time, if it is below these ranges, it is not sufficiently sterilized, and if it is above these ranges, the components contained in the mixed solution will be altered. It is preferable to sterilize at 60 to 95 ° C. for 30 to 50 minutes. In step S7, the mixed liquid of fruit juice and seed is sterilized, but only the fruit juice may be sterilized first.
次に、ステップS7でザクロ混合液を滅菌後、該混合液を孔径1.0〜1.5mmのフィルタで濾過をする(ステップS8)。なお、ステップS7の後、ザクロ混合液を一旦冷却後にステップS8に移行することが望ましいが、該ザクロ混合液を冷却せずに速やかにステップS7からS8に移行しても構わない。ここで、ステップS8における濾過を第1濾過とする。前記第1濾過の目的は、種子の外種皮を取り除くことである。フィルタの孔径が1.5mm以上であると、外種皮が濾液の中に混入する可能性がある。また、フィルタの孔径が1.0mm以下であると、外種皮は取り除かれるものの、外種皮の中に入り込んだ種子由来繊維質成分が濾液(混合液)に残らない可能性がある。 Next, after sterilizing the pomegranate mixture in step S7, the mixture is filtered through a filter having a pore size of 1.0 to 1.5 mm (step S8). Although it is desirable that after the step S7, the pomegranate mixture is once cooled, the process proceeds to step S8. However, the pomegranate mixture may not be cooled, and the process may be quickly shifted from step S7 to S8. Here, the filtration in step S8 is referred to as a first filtration. The purpose of the first filtration is to remove the seed coat. If the pore size of the filter is 1.5 mm or more, the outer seed coat may be mixed into the filtrate. Further, when the pore diameter of the filter is 1.0 mm or less, the seed seed fiber component that has entered the outer seed coat may not remain in the filtrate (mixed liquid) although the outer seed coat is removed.
次に、第1濾過後のザクロ混合液を、孔径0.1〜0.5mmのフィルタで濾過をする(ステップS9)。ここで、ステップS9における濾過を第2濾過とする。前記第2濾過の目的は、第1濾過で取り除かれなかった外種皮と、内種皮とを取り除くことにある。また、第2濾過に使用するフィルタは、孔径が0.1〜0.5mmであれば形状は特に問わない。また、フィルタの孔径が0.5mm以上であると、外種皮は完全に取り除かれるものの、内種皮が濾液に混入する可能性がある。また、フィルタの孔径が0.1mm未満であると、内種皮は完全に取り除かれるものの、種子由来繊維質成分が濾液(混合液)に残らない可能性がある。 Next, the pomegranate mixed solution after the first filtration is filtered with a filter having a pore diameter of 0.1 to 0.5 mm (step S9). Here, the filtration in step S9 is referred to as a second filtration. The purpose of the second filtration is to remove the outer seed coat and the inner seed coat that have not been removed by the first filtration. Moreover, the shape of the filter used for the second filtration is not particularly limited as long as the pore diameter is 0.1 to 0.5 mm. Further, when the pore diameter of the filter is 0.5 mm or more, the outer seed coat is completely removed, but the inner seed coat may be mixed into the filtrate. If the pore size of the filter is less than 0.1 mm, the inner seed coat is completely removed, but the seed-derived fiber component may not remain in the filtrate (mixed solution).
ここで、ステップS8及びS9における第1及び第2濾過に関して、第1濾過及び第2濾過に使用するフィルタの形状は円盤(ふるい)型、円筒型等特に問わない。またフィルタの孔の形状は、1.0〜1.5mm(第1濾過)及び0.1〜0.5mm(第2濾過)の孔径を確保できれば、円状、四辺形状、多角型状、線状、格子状等特に問わない。また、フィルタの材質は、スチール製、合成繊維製、プラスチック製などであるが、スチール製のものが望ましい。スチール製の場合、種子における外種皮及び内種皮のような硬い部分だけが取り除かれ、種子の繊維質部分がフィルタに付着するといったことが防止できるからである。また、第1及び第2濾過では同じ材質のフィルタを使用するのが望ましいが、材質の違うフィルタを使用しても良い。また、第1及び第2濾過共に、自然濾過、減圧濾過、加圧濾過など適宜選択可能である。 Here, regarding the first and second filtrations in steps S8 and S9, the shape of the filter used for the first filtration and the second filtration is not particularly limited, such as a disk type or a cylindrical type. Moreover, if the hole diameter of a filter can ensure the hole diameter of 1.0-1.5mm (1st filtration) and 0.1-0.5mm (2nd filtration), circular shape, quadrilateral shape, polygonal shape, line | wire There is no particular limitation on the shape and the lattice shape. Further, the material of the filter is made of steel, synthetic fiber, plastic, or the like, but steel is preferable. This is because in the case of steel, only hard parts such as the outer seed coat and inner seed coat in the seed are removed, and the fibrous part of the seed can be prevented from adhering to the filter. In the first and second filtrations, it is desirable to use filters of the same material, but filters of different materials may be used. Moreover, natural filtration, vacuum filtration, pressure filtration, etc. can be suitably selected for both the first and second filtrations.
次に、ステップS9で得られたザクロ混合液を、タンクなどの容器に入れ、Brix65±1%になるまで加熱濃縮する(ステップS10)。加熱温度、加熱時間は特に問わず、濃縮方法は従来技術で構わない。ここで、Brixとは、ショ糖(砂糖)溶液の濃度の単位で、20℃におけるザクロ果汁溶液100グラム中の糖類のグラム数を、ショ糖のグラム数に換算した値を重量百分率で表すものである。 Next, the pomegranate mixture obtained in step S9 is put into a container such as a tank, and concentrated by heating until Brix 65 ± 1% (step S10). The heating temperature and the heating time are not particularly limited, and the concentration method may be a conventional technique. Here, Brix is a unit of the concentration of sucrose (sugar) solution, and represents the value obtained by converting the number of grams of saccharide in 100 grams of pomegranate juice solution at 20 ° C. into the number of grams of sucrose as a percentage by weight. It is.
ステップS10の後、適宜冷却し、瓶詰めして出荷する(ステップS11)。ステップS11にて使用する瓶(容器)は、ガラス瓶、プラスチック(ポリ容器)、紙パックなどである。 After step S10, the product is appropriately cooled, bottled and shipped (step S11). The bottle (container) used in step S11 is a glass bottle, a plastic (poly container), a paper pack, or the like.
次に、本発明の種子入りザクロジュースの製造方法で製造された種子入りザクロジュースについて説明する。 Next, the seeded pomegranate juice produced by the method for producing seeded pomegranate juice of the present invention will be described.
該製造方法で製造された種子入りザクロジュースの成分を分析したところ、種子由来繊維質(主に食物繊維)成分、蛋白質、ブドウ糖や果糖等の糖類、ポリフェノール、ナトリウム並びにカリウム及びカルシウムなどのミネラル類等が確認された。また、種子由来繊維質(主に食物繊維)成分に付着したエストロゲンの一種であるエストラジオールも検出された。また、その他のエストロゲン類(エストリオール、エストロン)も確認された。その他、ビタミンC、ビタミンB類(B1及びB2)も確認された。 Analysis of the components of seeded pomegranate juice produced by the production method revealed seed-derived fiber (mainly dietary fiber) components, proteins, sugars such as glucose and fructose, polyphenols, sodium, and minerals such as potassium and calcium. Etc. were confirmed. Moreover, estradiol which is a kind of estrogen adhering to the seed-derived fiber (mainly dietary fiber) component was also detected. Other estrogens (estriol and estrone) were also confirmed. In addition, vitamin C and vitamin B (B1 and B2) were also confirmed.
次に、本発明の種子入りザクロジュースを使用したザクロ果汁入りゼリーの製造の概要について、図3のフローチャートを基に説明する。 Next, an outline of production of jelly with pomegranate juice using the pomegranate juice with seeds of the present invention will be described based on the flowchart of FIG.
先ず、図1のステップS11にて出荷された種子入りザクロジュース(ザクロ果汁)は、Brix65±1%であるため、該ザクロ果汁入りゼリーを製造する際は、水で2倍以上、好ましくは2〜20倍程度に希釈したものを使用する(ステップS31)。種子入りザクロジュースをそのまま、即ち希釈しないと、コラーゲンやプラセンタエキスと、凝固剤とが反応してしまい、凝固しない。この理由として、ザクロジュースのpH値(水素イオン濃度)が影響する。一方、20倍以上に希釈してしまうと、ミネラルやビタミン類などのザクロ由来成分が、十分に摂取できない。 First, since the pomegranate juice containing seeds (pomegranate juice) shipped in step S11 of FIG. 1 is Brix 65 ± 1%, when manufacturing the jelly containing pomegranate juice, it is twice or more with water, preferably 2 The one diluted to about 20 times is used (step S31). If the pomegranate juice with seeds is left as it is, that is, if it is not diluted, collagen and placenta extract will react with the coagulant and will not coagulate. For this reason, the pH value (hydrogen ion concentration) of pomegranate juice is affected. On the other hand, if diluted 20 times or more, pomegranate-derived components such as minerals and vitamins cannot be sufficiently ingested.
次にステップS31にて希釈した種子入りザクロジュースに対し、コラーゲン類、プラセンタエキス、保湿成分、凝固剤を配合する(ステップS32)。なお、配合順は、凝固剤を最後に配合する以外は特に順番は問わない。 Next, collagens, placenta extract, a moisturizing component, and a coagulant are blended into the pomegranate juice with seeds diluted in step S31 (step S32). The order of blending is not particularly limited except that the coagulant is blended last.
コラーゲン類としては、低分子化した、分子量が500〜5000のコラーゲンペプチドを使用するのが望ましい。分子量が500以下であると、凝固剤やザクロ果汁そのものと反応し、コラーゲン成分がアミノ酸にまで分解する。分子量が5000以上であると、コラーゲン成分が元来果たすべき機能が果たせなくなる可能性がある。なお、前記コラーゲンペプチドの配合量は、前記ザクロ果汁入りゼリー100重量%に対して、0.6〜5重量%、好ましくは0.6〜1重量%が望ましい。配合量が0.6重量%以下であると、コラーゲン成分が元来果たすべき機能が果たせなくなり、5重量%以上であると、凝固剤と反応し、コラーゲン成分が分解してしまう可能性がある。 As the collagen, it is desirable to use a collagen peptide having a low molecular weight and a molecular weight of 500 to 5,000. When the molecular weight is 500 or less, it reacts with the coagulant or pomegranate juice itself, and the collagen component is decomposed into amino acids. If the molecular weight is 5,000 or more, there is a possibility that the function that the collagen component should originally perform cannot be performed. In addition, the compounding quantity of the said collagen peptide is 0.6 to 5 weight% with respect to 100 weight% of the said jelly containing pomegranate juice, Preferably 0.6 to 1 weight% is desirable. If the blending amount is 0.6% by weight or less, the collagen component cannot perform its original function, and if it is 5% by weight or more, it may react with the coagulant and decompose the collagen component. .
プラセンタエキスは、豚由来のものが望ましいが、その限りではない。また、プラセンタエキスは、コラーゲン成分と同質の性質を有するため、コラーゲン類と共に用いるのが望ましいが、別に配合しなくても構わない。逆にコラーゲン成分の代わりにプラセンタエキスを使用しても構わない。プラセンタエキスを配合する場合、コラーゲン類同様、前記ザクロ果汁入りゼリー100重量%に対して、0.6〜5重量%、好ましくは0.6〜1重量%が望ましい。配合量が0.6重量%以下であると、プラセンタエキス由来成分が元来果たすべき機能が果たせなくなり、5重量%以上であると、凝固剤と反応し、プラセンタエキスが分解してしまう可能性がある。 The placenta extract is preferably derived from pigs, but is not limited thereto. In addition, since placenta extract has the same properties as the collagen component, it is preferably used together with collagens, but it may not be added separately. Conversely, placenta extract may be used instead of the collagen component. When a placenta extract is blended, the amount is 0.6 to 5% by weight, preferably 0.6 to 1% by weight, based on 100% by weight of the jelly containing pomegranate juice, like collagens. If the blending amount is 0.6% by weight or less, the placenta extract-derived component cannot perform its original function, and if it is 5% by weight or more, it may react with the coagulant and decompose the placenta extract. There is.
次に、保湿成分であるが、コラーゲン類、ヒアルロン酸、トレハロース、ヒアルロン酸ナトリウム、アロエベラジェル、植物性グリセリン、ベタイン、キトサン、PCAソーダ(ピロリドンカルボン酸ナトリウム)、プルラン、ローヤルゼリー、デオキシリボ核酸ナトリウム、リボ核酸ナトリウム、ナイアシンアミドなどの物質が使用可能である。ちなみに、コラーゲン類(前記コラーゲンペプチド)のみでも本発明のザクロ果汁入りゼリーは成立するが、水分含有力やその他の成分(凝固剤やザクロ果汁)との相性を考慮した場合、ヒアルロン酸及び/又はトレハロースを更に配合することが望ましい。なお、ヒアルロン酸及びトレハロースについては、共に配合しても、また、どちらか一方を配合しても良い。前記保湿成分の配合量は、前記ザクロ果汁入りゼリー100重量%に対して、0.2重量%以上、好ましくは0.2〜1重量%であれば構わない。 Next, as moisturizing ingredients, collagens, hyaluronic acid, trehalose, sodium hyaluronate, aloe vera gel, vegetable glycerin, betaine, chitosan, PCA soda (sodium pyrrolidonecarboxylate), pullulan, royal jelly, deoxyribonucleic acid sodium, ribo Substances such as nucleic acid sodium and niacinamide can be used. Incidentally, the jelly with pomegranate juice of the present invention can be established only with collagens (collagen peptide), but considering the water content and compatibility with other components (coagulant and pomegranate juice), hyaluronic acid and / or It is desirable to further add trehalose. In addition, about hyaluronic acid and trehalose, you may mix | blend together and may mix | blend any one. The amount of the moisturizing component may be 0.2% by weight or more, preferably 0.2 to 1% by weight with respect to 100% by weight of the jelly containing pomegranate juice.
次に、凝固剤については、ペクチン、カラギーナン、寒天、ゼラチンなどが使用可能であるが、ザクロ果汁との相性、即ちザクロ果汁の酸性度等を考慮した場合、ペクチンが望ましい。ペクチンの配合量は、前記ザクロ果汁入りゼリー100重量%に対して、1重量%〜10重量%添加される。ペクチンの配合量が1重量%以下であると十分に凝固せず、10重量%以上であると、コラーゲン成分等と反応してしまう。 Next, pectin, carrageenan, agar, gelatin and the like can be used as the coagulant, but pectin is desirable in consideration of compatibility with pomegranate juice, that is, acidity of pomegranate juice. The amount of pectin added is 1 to 10% by weight with respect to 100% by weight of the jelly containing pomegranate juice. If the blending amount of pectin is 1% by weight or less, the pectin is not sufficiently solidified, and if it is 10% by weight or more, it reacts with a collagen component or the like.
その他、ビタミンC、クエン酸、甘味料、ザクロ香料を適宜添加する。本発明に係るザクロ果汁入りゼリーにおいて、ビタミンC及びクエン酸については、ザクロ果汁の栄養補充(ビタミンC)、酸化防止剤、緩衝剤(コラーゲン成分と凝固剤との反応における)などの役割を担うが、添加しなくても構わない。ビタミンC及びクエン酸を添加する場合の配合量は、前記ザクロ果汁入りゼリー100重量%に対して、0.2重量%以上添加すれば良い。 In addition, vitamin C, citric acid, sweetener, and pomegranate flavor are added as appropriate. In the jelly containing pomegranate juice according to the present invention, vitamin C and citric acid play a role of nutrient supplementation (vitamin C), antioxidant, buffer (in the reaction between the collagen component and the coagulant), etc. However, it may not be added. What is necessary is just to add 0.2weight% or more of the compounding quantity in the case of adding a vitamin C and a citric acid with respect to 100 weight% of the said jelly with pomegranate juice.
また、甘味料及びザクロ香料については、添加してもしなくてもどちらでも構わない。なお、甘味料については、砂糖、スクラロース、アスパルファムKなど、種類は問わない。また、甘味料及びザクロ香料についての配合量に特に制限は無い(大体1重量%以下である)。なお、ザクロ香料の代わり若しくは併用して、ローズオイルの使用も可能である。ローズオイルは、サプリメント等に使用されるブルガリア、ダマスク、ヴェレダ等が望ましい。ローズオイルの使用は、ザクロ果汁の栄養補充や、該オイルに含まれるビタミンE、リコピンの抗酸化作用が期待される。 In addition, the sweetener and the pomegranate flavor may or may not be added. The sweetener may be of any type, such as sugar, sucralose, and asparfum K. Moreover, there is no restriction | limiting in particular about the compounding quantity about a sweetener and a pomegranate flavor (it is about 1 weight% or less). It is also possible to use rose oil instead of or in combination with the pomegranate flavor. As for rose oil, Bulgaria, damask, weleda, etc. used for a supplement etc. are desirable. The use of rose oil is expected to supplement the nutrition of pomegranate juice and the antioxidant effect of vitamin E and lycopene contained in the oil.
ステップS32における、材料の配合の後、冷暗所にて2時間以上静置して、本発明に係るザクロ果汁入りゼリーとする(ステップS33)。 After blending the materials in step S32, the mixture is allowed to stand for 2 hours or more in a cool and dark place to obtain the jelly with pomegranate juice according to the present invention (step S33).
なお、本発明に係るザクロ果汁入りゼリーは、グミキャンディーへの応用も可能である。 Note that the jelly with pomegranate juice according to the present invention can also be applied to gummy candy.
以上、本発明に係る種子入りザクロジュースの製造方法、該製造方法から成る種子入りザクロジュース及び該種子入りザクロジュースを使用して成るザクロ果汁入りゼリーについて説明したが、本発明の実施形態はこの限りではない。 As described above, the method for producing pomegranate juice with seeds according to the present invention, the pomegranate juice with seeds comprising the production method, and the jelly with pomegranate juice using the pomegranate juice with seeds have been described. Not as long.
次に、上記に述べた本発明の実施形態の詳細を、実施例を基に説明する。 Next, details of the embodiment of the present invention described above will be described based on examples.
[実施例1]種子入りザクロジュースの製造
先ず、イラン・ザクロス山脈産の赤ペルシャザクロ及び黒ペルシャザクロを、10月に収穫し、収穫した該ザクロをベルトコンベア上で選別し、選別の後に洗浄した。本実施例では、赤ペルシャザクロ(赤身ザクロ)及び黒ペルシャザクロ(黒ザクロ)の混合使用比率を1:1とし、本発明に係る種子入りザクロジュース1kgに対し、9.8kgのザクロを使用した。
[Example 1] Manufacture of seeded pomegranate juice First, red persian pomegranate and black persian pomegranate from Iran and Zakros Mountains were harvested in October, and the harvested pomegranate was sorted on a belt conveyor and washed after sorting. did. In this example, the mixture use ratio of red persian pomegranate (red pomegranate) and black persian pomegranate (black pomegranate) was 1: 1, and 9.8 kg of pomegranate was used for 1 kg of seeded pomegranate juice according to the present invention. .
次に、洗浄後の赤ペルシャザクロ及び黒ペルシャザクロの全果を、粉砕機を用いて潰した後、果皮を取り除き、更にそれ以外の部分、即ち果実(果肉及び種子)部分を遠心分離機にて果肉と種子に分離した。ここで、果肉については搾って果汁にし、種子についてはスクリュー型押圧機で粒状にした。 Next, after crushing the whole fruit of the washed red persian pomegranate and black persian pomegranate using a pulverizer, the pericarp is removed, and the other parts, that is, the fruit (fruit and seed) parts are placed in a centrifuge. And separated into pulp and seeds. Here, the pulp was squeezed into fruit juice, and the seeds were granulated with a screw-type pressing machine.
次に、前記果汁と、粒状の前記種子とを混合して得られたザクロ混合液(本発明に係る種子入りザクロジュース原液)を、90℃で40分間滅菌を行った。 Next, the pomegranate mixture obtained by mixing the fruit juice and the granular seeds (seed pomegranate juice stock solution according to the present invention) was sterilized at 90 ° C. for 40 minutes.
前記滅菌の後、前記ザクロ混合液に関して、孔径が1.2mmのステンレススチール316製フィルタで1回目の濾過(第1濾過)をした。続けて、前記第1濾過後に孔径が0.3mmのステンレススチール316製フィルタで2回目の濾過(第2濾過)をした。 After the sterilization, the pomegranate mixed solution was subjected to the first filtration (first filtration) with a stainless steel 316 filter having a pore diameter of 1.2 mm. Subsequently, after the first filtration, the second filtration (second filtration) was performed with a stainless steel 316 filter having a pore diameter of 0.3 mm.
前記第2濾過後、濾過された前記ザクロ混合液をタンクに回収し、該タンク内で加熱濃縮を行った。前記濃縮は、Brix65%になるまで加熱した。ここで本発明(本実施例)に係る種子入りザクロジュースが完成した。 After the second filtration, the filtered pomegranate mixture was collected in a tank and concentrated by heating in the tank. The concentration was heated to Brix 65%. Here, the pomegranate juice with seeds according to the present invention (this example) was completed.
次に前記種子入りザクロジュースを適宜冷却し、そしてガラス瓶に瓶詰めし、出荷した。 Next, the pomegranate juice with seeds was cooled as appropriate, and bottled into a glass jar and shipped.
以上、本発明に係る種子入りザクロジュースの製造方法に関する実施例を説明したが、本実施例はあくまで一例であり、ザクロの収穫時期、赤ペルシャザクロ及び黒ペルシャザクロを使用したときの混合使用比率、滅菌温度等の種々の条件はこの限りではない。 As mentioned above, although the Example regarding the manufacturing method of the pomegranate juice with a seed concerning this invention was described, this Example is an example to the last, the mixture use ratio when using the harvest time of a pomegranate, red persian pomegranate and black persian pomegranate Various conditions such as sterilization temperature are not limited to this.
[実施例2]実施例1にて製造された種子入りザクロジュースの成分分析
実施例1にて製造された種子入りザクロジュースについて、エストロゲン由来成分以外の成分分析表について、表1に示す。なお、表1に示す成分分析表については、「栄養表示基準における栄養成分等の分析方法等について(衛新第13号平成11年4月26日)」によった。
[Example 2] Component analysis of pomegranate juice with seeds produced in Example 1 Table 1 shows a component analysis table for the pomegranate juice with seeds produced in Example 1 other than the components derived from estrogen. In addition, the component analysis table shown in Table 1 is based on “Analysis method of nutritional components and the like in the nutrition labeling standards (Ashin No. 13, April 26, 1999)”.
上記表1の結果から、食物繊維(種子由来繊維質成分)、蛋白質、脂質、ブドウ糖や果糖等の糖類(上記表1では糖質として)、カリウム及びカルシウムなどのミネラル類(上記表1では灰分として)、ナトリウム並びにポリフェノールが検出された。なお、上記表1にて示さなかったが、ビタミンC、ビタミンB類(B1及びB2)についても別法にて検出された。 From the results in Table 1 above, dietary fiber (seed-derived fiber component), proteins, lipids, sugars such as glucose and fructose (as saccharides in Table 1 above), minerals such as potassium and calcium (in Table 1 above, ash content) As well) sodium and polyphenols were detected. Although not shown in Table 1, vitamin C and vitamin B (B1 and B2) were also detected by other methods.
次に、エストロゲン3画分(エストロン、17β−エストラジオール及びエストリオール)について、RIA(ラジオイムノアッセイ)法で分析したところ、参考値ではあるが、エストロン、エストロン及び17β−エストラジオールについては本発明に係る種子入りザクロジュース1mLあたり、1〜1000pg(ピコグラム)レベルでの検出が確認された。なお、薬事法に抵触するので具体的な数値は伏せる。 Next, the estrogen 3 fraction (estrone, 17β-estradiol and estriol) was analyzed by RIA (radioimmunoassay) method. As reference values, estrone, estrone and 17β-estradiol were seeds according to the present invention. Detection at a level of 1-1000 pg (picogram) per 1 mL of pomegranate juice was confirmed. In addition, since it conflicts with the Pharmaceutical Affairs Law, the specific numerical value can be hidden.
[実施例3]本発明に係るザクロ果汁入りゼリーの製造
実施例3では、本発明に係るザクロ果汁入りゼリーの実施例を説明する。
[Example 3] Production of jelly with pomegranate juice according to the present invention In Example 3, an example of the jelly with pomegranate juice according to the present invention will be described.
先ず、本発明に係る種子入りザクロジュース(本実施例1にて製造された種子入りザクロジュース)を水で2倍に希釈した。 First, the pomegranate juice with seeds according to the present invention (the pomegranate juice with seeds produced in Example 1) was diluted twice with water.
次に希釈した前記種子入りザクロジュースを15mL中に、トレハロース50mg、魚由来のコラーゲン(コラーゲンペプチド。平均分子量2000〜3000のものを使用)100mg、豚由来プラセンタエキス50mg、クエン酸50mg、ビタミンC50mg、ヒアルロン酸30mg、及びペクチン200mgを配合した。なお、ザクロ香料及び甘味料を少量配合した。 Next, in 15 mL of the diluted pomegranate juice with seeds, trehalose 50 mg, fish-derived collagen (collagen peptide, using an average molecular weight of 2000 to 3000) 100 mg, pig-derived placenta extract 50 mg, citric acid 50 mg, vitamin C 50 mg, 30 mg of hyaluronic acid and 200 mg of pectin were blended. A small amount of pomegranate flavor and sweetener were blended.
該配合後、ザクロ果汁入りゼリー溶液を冷暗所にて3時間静置して、凝固させることにより本発明に係るザクロ果汁入りゼリーとした。 After the blending, the pomegranate juice-containing jelly solution was allowed to stand in a cool and dark place for 3 hours and solidified to obtain a pomegranate juice-containing jelly according to the present invention.
[実施例4]本発明に係るザクロ果汁入りゼリーの製造の別態様
上記実施例3にて使用したザクロ香料の代わりに、ローズオイル(ブルガリア)を使用した。なお、ローズオイル以外のその他の材料の配合量や製造条件等は実施例3と同じである。
[Example 4] Another embodiment of production of jelly with pomegranate juice according to the present invention Rose oil (Bulgaria) was used in place of the pomegranate flavor used in Example 3 above. In addition, the compounding quantity of other materials other than rose oil, manufacturing conditions, etc. are the same as Example 3.
以上、本発明に係る種子入りザクロジュースの製造方法に関する実施例1として説明したが、本実施例はあくまで一例であり、ザクロの収穫時期、赤ペルシャザクロ及び黒ペルシャザクロを使用したときの混合使用比率、滅菌温度等の種々の条件はこの限りではない。 As mentioned above, although it demonstrated as Example 1 regarding the manufacturing method of the pomegranate juice containing a seed concerning this invention, this Example is an example to the last, mixed use when using a pomegranate harvest time, a red persian pomegranate, and a black persian pomegranate Various conditions such as ratio and sterilization temperature are not limited to this.
また、本発明に係るザクロ果汁入りゼリーについて、実施例3及び4にて説明したが、上記の実施例に限定されるものではない。 Moreover, although the pomegranate juice containing jelly which concerns on this invention was demonstrated in Example 3 and 4, it is not limited to said Example.
1 果実部分
2 果肉
3 種子
1
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010277818A JP5770462B2 (en) | 2010-07-22 | 2010-12-14 | Method for producing seeded pomegranate juice, seeded pomegranate juice comprising the production method, and pomegranate juice-containing jelly using the seeded pomegranate juice |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010164467 | 2010-07-22 | ||
JP2010164467 | 2010-07-22 | ||
JP2010277818A JP5770462B2 (en) | 2010-07-22 | 2010-12-14 | Method for producing seeded pomegranate juice, seeded pomegranate juice comprising the production method, and pomegranate juice-containing jelly using the seeded pomegranate juice |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015128891A Division JP5933789B2 (en) | 2010-07-22 | 2015-06-26 | Method for producing pomegranate juice with seeds |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012039997A true JP2012039997A (en) | 2012-03-01 |
JP5770462B2 JP5770462B2 (en) | 2015-08-26 |
Family
ID=45897023
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010277818A Active JP5770462B2 (en) | 2010-07-22 | 2010-12-14 | Method for producing seeded pomegranate juice, seeded pomegranate juice comprising the production method, and pomegranate juice-containing jelly using the seeded pomegranate juice |
JP2015128891A Active JP5933789B2 (en) | 2010-07-22 | 2015-06-26 | Method for producing pomegranate juice with seeds |
JP2016073911A Pending JP2016144465A (en) | 2010-07-22 | 2016-04-01 | Jelly containing pomegranate juice formed by using pomegranate juice containing seed |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015128891A Active JP5933789B2 (en) | 2010-07-22 | 2015-06-26 | Method for producing pomegranate juice with seeds |
JP2016073911A Pending JP2016144465A (en) | 2010-07-22 | 2016-04-01 | Jelly containing pomegranate juice formed by using pomegranate juice containing seed |
Country Status (1)
Country | Link |
---|---|
JP (3) | JP5770462B2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104489437A (en) * | 2014-12-11 | 2015-04-08 | 彭超昀莉 | Processing method of sweet osmanthus flower tomato health tea |
CN104489824A (en) * | 2015-01-22 | 2015-04-08 | 孙中贯 | Pomegranate flower tea beverage and making method thereof |
CN105249087A (en) * | 2015-09-11 | 2016-01-20 | 安徽丰原马鞍山生物化学有限公司 | Processing method for pomegranate condensed juice |
JP2016506758A (en) * | 2013-02-15 | 2016-03-07 | ペプシコ, インコーポレイテッドPepsiCo Inc. | Inclusion and preparation of co-products in beverages to improve nutritional and sensory characteristics |
JP2016144465A (en) * | 2010-07-22 | 2016-08-12 | 株式会社クワン | Jelly containing pomegranate juice formed by using pomegranate juice containing seed |
CN106901266A (en) * | 2017-01-24 | 2017-06-30 | 钦州市钦南区科学技术情报研究所 | A kind of preparation method of the flue dried fruit rich in anthocyanidin |
CN111938050A (en) * | 2020-08-11 | 2020-11-17 | 安徽天环生物科技有限公司 | Method for producing fresh pomegranate juice at low temperature |
CN114027504A (en) * | 2021-12-01 | 2022-02-11 | 山东美果来食品有限公司 | Preparation method of probiotic pomegranate juice beverage |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106306883A (en) * | 2016-08-19 | 2017-01-11 | 成都红石榴农业开发股份有限公司 | Production method of pomegranate concentrated juice |
KR102286199B1 (en) * | 2020-10-08 | 2021-08-05 | (주)원아 | Pomegranate Juice with High Concentration of Ellagic Acid and Manufacturing Method Thereof |
Citations (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08508638A (en) * | 1993-02-16 | 1996-09-17 | ザ、プロクター、エンド、ギャンブル、カンパニー | Sweet drink and sweet composition |
JPH11103779A (en) * | 1997-10-08 | 1999-04-20 | Shoji Sakai | Production of dessert cake from vegetable |
JP2000023637A (en) * | 1998-05-06 | 2000-01-25 | Ehime Kankitsu Shigen Kaihatsu Kenkyusho:Kk | Production of highly carotenoid-containing powder originated from citrous juice |
JP2000143508A (en) * | 1998-11-05 | 2000-05-23 | Taiyo Kagaku Co Ltd | Premenstrual syndrome depressant composition |
JP2001145474A (en) * | 1999-11-18 | 2001-05-29 | Nikken Foods Co Ltd | Antioxidative and immune-improving beverage and method for producing the same |
JP2001286268A (en) * | 2000-04-05 | 2001-10-16 | Kanegafuchi Chem Ind Co Ltd | Method for improving efficiency of energy ingestion |
JP2002051734A (en) * | 2000-08-08 | 2002-02-19 | Nitta Gelatin Inc | Collagen added food and drink |
JP2002105483A (en) * | 2000-09-28 | 2002-04-10 | Kanegafuchi Chem Ind Co Ltd | Method for treating pomegranate seed |
JP2003009817A (en) * | 2001-07-03 | 2003-01-14 | Persia Zakuro Yakuhin:Kk | Pomegranate extract |
JP2003102431A (en) * | 2001-09-28 | 2003-04-08 | Persia Zakuro Yakuhin:Kk | Pomegranate essence |
JP2003113028A (en) * | 2001-09-28 | 2003-04-18 | Persia Zakuro Yakuhin:Kk | Mixture of seed component of punica granatum |
JP2003116497A (en) * | 2001-10-05 | 2003-04-22 | Mari:Kk | Lactic fermentation drink of pomegranate |
JP2003514865A (en) * | 1999-11-29 | 2003-04-22 | リモネスト リミテッド | Mixture of pomegranate seed oil and fruit juice product |
JP2003183151A (en) * | 2001-11-09 | 2003-07-03 | Avon Products Inc | Topical use composition containing undifferentiated plant seed cell and method for using the same |
JP2003274888A (en) * | 2002-03-26 | 2003-09-30 | Takara Holdings Inc | Crushed fruit, and food and drink |
JP2004024150A (en) * | 2002-06-26 | 2004-01-29 | Iwaki No Kaasan:Kk | Process for preparing mixed jam of carrot and pomegranate |
JP2004242663A (en) * | 2002-12-20 | 2004-09-02 | Toyo Shinyaku:Kk | Diet food |
JP2005075796A (en) * | 2003-09-02 | 2005-03-24 | Mukai Takashi | Method for extracting estrogenic substance and product mixed with estrogenic substance |
WO2006004106A1 (en) * | 2004-07-05 | 2006-01-12 | Marukin Bio, Inc. | Pomegranate juice, pomegranate juice powder and process for producing the powder |
JP2007131568A (en) * | 2005-11-09 | 2007-05-31 | Nippon Seiyaku Kogyo Kk | Immunostimulator and immunostimulating food and drink containing the same |
JP2007151549A (en) * | 2005-11-14 | 2007-06-21 | Kanebo Foods Ltd | Internal purification kit and internal purification method |
JP2008029698A (en) * | 2006-07-31 | 2008-02-14 | Zojirushi Corp | Foodstuff processor |
JP2008542283A (en) * | 2005-05-24 | 2008-11-27 | ポム ワンダフル エルエルシー | Method for extracting vegetation chemicals from pomegranate solids, composition thereof and method of use |
WO2009016620A2 (en) * | 2007-07-27 | 2009-02-05 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center | Pomegranate sprouts, preparations derived therefrom and compositions comprising same |
WO2009031023A2 (en) * | 2007-09-07 | 2009-03-12 | Probelte Pharma, S.A. | Pomegranate extracts, nutritional products containing them and their uses |
JP2010022330A (en) * | 2008-07-24 | 2010-02-04 | Tonbo Inryo:Kk | Ice cream of jelly |
JP2010094112A (en) * | 2008-10-20 | 2010-04-30 | Ito En Ltd | Method for improving taste of vegetable juice and method for producing vegetable juice |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60118168A (en) * | 1983-11-30 | 1985-06-25 | Tatsumi Kikaku:Kk | Production of date powder |
JPS60256368A (en) * | 1984-05-31 | 1985-12-18 | Miyoshi Oil & Fat Co Ltd | Spread food containing vegetable or/and fruit and production thereof |
JP3313391B2 (en) * | 1992-03-02 | 2002-08-12 | 株式会社富士商事 | Pulp-like jelly and method for producing the same |
US5479851A (en) * | 1994-05-25 | 1996-01-02 | Breville Pty Ltd. | Fruit and vegetable juicer |
JPH10234319A (en) * | 1997-02-25 | 1998-09-08 | Ichimaru Pharcos Co Ltd | Propolis extract-containing composition |
JP2004033016A (en) * | 2002-06-28 | 2004-02-05 | Matsubara Seianjo:Kk | Method for producing puff jelly |
JP5326821B2 (en) * | 2009-05-28 | 2013-10-30 | 市光工業株式会社 | Lighting fixtures for vehicles |
JP5770462B2 (en) * | 2010-07-22 | 2015-08-26 | 株式会社クワン | Method for producing seeded pomegranate juice, seeded pomegranate juice comprising the production method, and pomegranate juice-containing jelly using the seeded pomegranate juice |
JP2015128891A (en) * | 2013-12-05 | 2015-07-16 | 株式会社パイロットコーポレーション | Writing instrument refill storage body, writing instrument body and writing instrument set |
-
2010
- 2010-12-14 JP JP2010277818A patent/JP5770462B2/en active Active
-
2015
- 2015-06-26 JP JP2015128891A patent/JP5933789B2/en active Active
-
2016
- 2016-04-01 JP JP2016073911A patent/JP2016144465A/en active Pending
Patent Citations (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08508638A (en) * | 1993-02-16 | 1996-09-17 | ザ、プロクター、エンド、ギャンブル、カンパニー | Sweet drink and sweet composition |
JPH11103779A (en) * | 1997-10-08 | 1999-04-20 | Shoji Sakai | Production of dessert cake from vegetable |
JP2000023637A (en) * | 1998-05-06 | 2000-01-25 | Ehime Kankitsu Shigen Kaihatsu Kenkyusho:Kk | Production of highly carotenoid-containing powder originated from citrous juice |
JP2000143508A (en) * | 1998-11-05 | 2000-05-23 | Taiyo Kagaku Co Ltd | Premenstrual syndrome depressant composition |
JP2001145474A (en) * | 1999-11-18 | 2001-05-29 | Nikken Foods Co Ltd | Antioxidative and immune-improving beverage and method for producing the same |
JP2003514865A (en) * | 1999-11-29 | 2003-04-22 | リモネスト リミテッド | Mixture of pomegranate seed oil and fruit juice product |
JP2001286268A (en) * | 2000-04-05 | 2001-10-16 | Kanegafuchi Chem Ind Co Ltd | Method for improving efficiency of energy ingestion |
JP2002051734A (en) * | 2000-08-08 | 2002-02-19 | Nitta Gelatin Inc | Collagen added food and drink |
JP3574612B2 (en) * | 2000-08-08 | 2004-10-06 | 新田ゼラチン株式会社 | Food and drink with collagen |
JP2002105483A (en) * | 2000-09-28 | 2002-04-10 | Kanegafuchi Chem Ind Co Ltd | Method for treating pomegranate seed |
JP2003009817A (en) * | 2001-07-03 | 2003-01-14 | Persia Zakuro Yakuhin:Kk | Pomegranate extract |
JP2003102431A (en) * | 2001-09-28 | 2003-04-08 | Persia Zakuro Yakuhin:Kk | Pomegranate essence |
JP2003113028A (en) * | 2001-09-28 | 2003-04-18 | Persia Zakuro Yakuhin:Kk | Mixture of seed component of punica granatum |
JP2003116497A (en) * | 2001-10-05 | 2003-04-22 | Mari:Kk | Lactic fermentation drink of pomegranate |
JP3785424B2 (en) * | 2001-10-05 | 2006-06-14 | 上地 俊徳 | Pomegranate Lactic Acid Fermented Beverage |
JP2003183151A (en) * | 2001-11-09 | 2003-07-03 | Avon Products Inc | Topical use composition containing undifferentiated plant seed cell and method for using the same |
JP2003274888A (en) * | 2002-03-26 | 2003-09-30 | Takara Holdings Inc | Crushed fruit, and food and drink |
JP2004024150A (en) * | 2002-06-26 | 2004-01-29 | Iwaki No Kaasan:Kk | Process for preparing mixed jam of carrot and pomegranate |
JP2004242663A (en) * | 2002-12-20 | 2004-09-02 | Toyo Shinyaku:Kk | Diet food |
JP2005075796A (en) * | 2003-09-02 | 2005-03-24 | Mukai Takashi | Method for extracting estrogenic substance and product mixed with estrogenic substance |
WO2006004106A1 (en) * | 2004-07-05 | 2006-01-12 | Marukin Bio, Inc. | Pomegranate juice, pomegranate juice powder and process for producing the powder |
JP2008542283A (en) * | 2005-05-24 | 2008-11-27 | ポム ワンダフル エルエルシー | Method for extracting vegetation chemicals from pomegranate solids, composition thereof and method of use |
JP2007131568A (en) * | 2005-11-09 | 2007-05-31 | Nippon Seiyaku Kogyo Kk | Immunostimulator and immunostimulating food and drink containing the same |
JP2007151549A (en) * | 2005-11-14 | 2007-06-21 | Kanebo Foods Ltd | Internal purification kit and internal purification method |
JP2008029698A (en) * | 2006-07-31 | 2008-02-14 | Zojirushi Corp | Foodstuff processor |
WO2009016620A2 (en) * | 2007-07-27 | 2009-02-05 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center | Pomegranate sprouts, preparations derived therefrom and compositions comprising same |
WO2009031023A2 (en) * | 2007-09-07 | 2009-03-12 | Probelte Pharma, S.A. | Pomegranate extracts, nutritional products containing them and their uses |
JP2010022330A (en) * | 2008-07-24 | 2010-02-04 | Tonbo Inryo:Kk | Ice cream of jelly |
JP2010094112A (en) * | 2008-10-20 | 2010-04-30 | Ito En Ltd | Method for improving taste of vegetable juice and method for producing vegetable juice |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016144465A (en) * | 2010-07-22 | 2016-08-12 | 株式会社クワン | Jelly containing pomegranate juice formed by using pomegranate juice containing seed |
JP2016506758A (en) * | 2013-02-15 | 2016-03-07 | ペプシコ, インコーポレイテッドPepsiCo Inc. | Inclusion and preparation of co-products in beverages to improve nutritional and sensory characteristics |
CN104489437A (en) * | 2014-12-11 | 2015-04-08 | 彭超昀莉 | Processing method of sweet osmanthus flower tomato health tea |
CN104489824A (en) * | 2015-01-22 | 2015-04-08 | 孙中贯 | Pomegranate flower tea beverage and making method thereof |
CN105249087A (en) * | 2015-09-11 | 2016-01-20 | 安徽丰原马鞍山生物化学有限公司 | Processing method for pomegranate condensed juice |
CN106901266A (en) * | 2017-01-24 | 2017-06-30 | 钦州市钦南区科学技术情报研究所 | A kind of preparation method of the flue dried fruit rich in anthocyanidin |
CN111938050A (en) * | 2020-08-11 | 2020-11-17 | 安徽天环生物科技有限公司 | Method for producing fresh pomegranate juice at low temperature |
CN114027504A (en) * | 2021-12-01 | 2022-02-11 | 山东美果来食品有限公司 | Preparation method of probiotic pomegranate juice beverage |
Also Published As
Publication number | Publication date |
---|---|
JP5933789B2 (en) | 2016-06-15 |
JP2016144465A (en) | 2016-08-12 |
JP2015211683A (en) | 2015-11-26 |
JP5770462B2 (en) | 2015-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5933789B2 (en) | Method for producing pomegranate juice with seeds | |
JP5613953B2 (en) | Use of functional materials containing citrus pulp in Wenzhou | |
KR100902539B1 (en) | Functional drink comprising abalone extract and the preparation method of thereof | |
CN101243895A (en) | Method for processing sweet potato beverage | |
CN1240316C (en) | Method for preparing pure seed water melon juice and series products thereof | |
CN105876544A (en) | Lycium chinensis fruit and lycium ruthenicum fruit compound drink and manufacture method thereof | |
CN104473084A (en) | Multi-vitamin nutrient chewable tablet prepared from blueberry peel and residues | |
CN103431328B (en) | Natural jackfruit powder and preparation method thereof | |
KR102523536B1 (en) | Fruits syrup comprising pericarp and manufacturing method of the same | |
CN101919567B (en) | Wheat malt drink and production method thereof | |
KR101072826B1 (en) | Composition additives of pork feed and preparation method thereof | |
CN106360207B (en) | Method for preparing chitosan oligosaccharide maca ginseng functional beverage and functional beverage prepared by same | |
KR20170060196A (en) | Meat sauce using fermented rice bran products and manufacturing method thereby | |
JP5248023B2 (en) | Calcium absorption promoting composition | |
JP6450593B2 (en) | Method for producing dry powder and use of dry powder | |
JP6872699B2 (en) | Composition for promoting calcium absorption | |
KR20090007512A (en) | Emotional tea with spicy, sweety collagen blueberry vita green tea | |
KR102104546B1 (en) | kudzu Liquid tea and its manufacturing method | |
KR20120084422A (en) | Method for preparing drink containing mulberry extracts | |
KR101296419B1 (en) | A portable water contaning cucumber and the method of making it | |
US10376554B1 (en) | Composition and method for treating a hangover | |
JP3053921U (en) | Conditioning food | |
CN103829334A (en) | Health beverage preparation method utilizing opuntia ficus-indica | |
CN109077207A (en) | A kind of sea-buckthorn pumpkin composite fruit juice formula and its processing technology | |
US11202758B1 (en) | Composition and method for treating a hangover |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20131011 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20131015 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20131011 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20141015 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20141111 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150109 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150616 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150625 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5770462 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |